Nutrient quality
A well-regarded form and meaningful amount create a focused supplement. The dose is balanced for routine use.
.| $ 36.98 | ||
Vitacost | $ 36.98 | |
| $ 36.98 |
Each serving supplies 90 mcg of long-acting MK-7 for practical daily calcium-handling support. The amount is more substantial than low-dose maintenance products without moving into very high-dose territory.
Softgel delivery is appropriate for vitamin K2, and the 120-serving package improves convenience. Generic sourcing without all-trans verification is the main quality uncertainty.
Long-term users who want K2 alone are the clearest fit. People needing vitamin D, calcium, magnesium, or broader cardiovascular nutrients must cover them separately.
A well-regarded form and meaningful amount create a focused supplement. The dose is balanced for routine use.
.The active form and amount are exceptionally clear with no hidden blend. Missing intake directions and softgel excipients are the only notable gaps.
.Aggregate satisfaction is very strong and supported by a substantial evidence base. No firsthand experience details are supplied, so recurring complaints and purpose alignment cannot be checked.
.High-quality forms and a favorable serving position create strong value. The package compares very well with similar vitamin K products.
.MK-7 provides targeted support for vitamin K-dependent proteins involved in bone mineral use. Its role is relevant and supported by established biological evidence.
The amount is clearly stated and uses a specific, longer-lasting form of vitamin K2. No calcium, vitamin D, magnesium, or matrix-building nutrient is included, which sharply limits pathway coverage.
Vitamin K2 as MK-7 provides direct calcium-management support that is relevant to arterial health. The focused ingredient does not address lipids, vascular tone, or cardiac energy.
The 90 mcg MK-7 amount is clearly disclosed, and the MK-7 form has a long duration of action. The single-pathway design is transparent and free of padding. Vitamin K can counteract warfarin and other vitamin K antagonist medicines, so users of those drugs need clinician-guided intake. No other meaningful product-specific concern is evident from the supplied formula.
Vitamin K2 has a plausible vascular role by supporting proteins that direct calcium away from arteries. Evidence supports effects on vitamin K status and calcification markers, while cardiovascular outcome evidence remains incomplete.
The 90 mcg MK-7 amount is a practical daily dose. The single-nutrient design is coherent, but vitamin K2 can oppose warfarin and other vitamin K antagonist anticoagulants.
| Ingredient | Amount per serving |
|---|---|
Vitamin K2 (Menaquinone-7) | 90 mcg |
The formula delivers a focused 90 mcg MK-7 serving in an absorption-friendly softgel. Its generic source lacks branded or all-trans confirmation. The larger count maintains exceptional cost efficiency.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.